The purpose of this rule development is to develop a negative formulary regarding injectable materials for acupuncturists in injection therapy adjunctive modalities.

DEPARTMENT OF HEALTH
Board of Acupuncture

RULE NO.: RULE TITLE:
64B1-4.012: Acupoint Injection Therapies
PURPOSE AND EFFECT: The purpose of this rule development is to develop a negative formulary regarding injectable materials for acupuncturists in injection therapy adjunctive modalities.
SUBJECT AREA TO BE ADDRESSED: Acupoint Injection Therapies.
RULEMAKING AUTHORITY: 457.102(1), 457.104 FS.
LAW IMPLEMENTED: 457.102 FS.
A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME: December 9, 2011, following the conclusion of the general business meeting.
PLACE: Holiday Inn & Suite, 2725 Graves Road, Tallahassee, FL 32303
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 5 days before the workshop/meeting by contacting: Anthony Jusevitch, Executive Director, Board of Acupuncture/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Anthony Jusevitch, Executive Director, Board of Acupuncture/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.